AI eye doctor: new tool aims to spot rare retinal diseases
NCT ID NCT06839170
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an artificial intelligence (AI) system called Retina4IRD that helps doctors diagnose inherited retinal diseases, which are rare eye conditions that can cause vision loss. The AI looks at eye images and patient information to suggest which gene might be causing the disease. Researchers tested it with 295 people and measured how often the AI's top five guesses included the correct gene. The goal is to make diagnosis faster and more accurate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI diagnostic system (FM-IRDs / Retina4IRD)
What this could lead to
If successful, this AI could help doctors diagnose inherited retinal diseases faster and more accurately, potentially improving patient care.
What could go wrong
This is a completed trial, but the AI's accuracy may not be perfect in all cases, and it may not work as well in different populations or real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INHERITED RETINAL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai General Hospital, Shanghai Jiao Tong University
Shanghai, 200080, China
-
Shanghai general hospital
Shanghai, China